RXRX - RECURSION PHARMACEUTICALS, INC.

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-60.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-851%)	-56.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-801%)	681.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8422%)	-80.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1102%)	33.3% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+317%)	6.9% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-14%)	-58.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-828%)	147.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1745%)	30.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+286%)	13.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+71%)	-20.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-355%)	-20.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-350%)	43.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+445%)	127.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1494%)	439.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5399%)	419.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5142%)	201.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2413%)	108.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1252%)	-5.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-173%)	147.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1740%)	1270.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15780%)	4170.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+52025%)	—	—	—	—	—	—
EPS Growth YoY (%)	39.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	56.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	70.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-5.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-28.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	20.9% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-5.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-14.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-40.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-22.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-3.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	23.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-22.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	75.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	74.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-56.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	23.8% Good ↑ Good Improving Year-over-year change in net income	42.0% Excellent ↑ Excellent Improving Year-over-year change in net income	39.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-69.3% Weak ↑ Weak Improving Year-over-year change in net income	-76.2% Weak ↓ Weak Declining Year-over-year change in net income	-121.6% Weak ↓ Weak Declining Year-over-year change in net income	-92.4% Weak ↓ Weak Declining Year-over-year change in net income	-3.0% Weak ↑ Weak Improving Year-over-year change in net income	-27.1% Weak ↑ Weak Improving Year-over-year change in net income	-39.9% Weak ↑ Weak Improving Year-over-year change in net income	-61.8% Weak ↓ Weak Declining Year-over-year change in net income	-53.9% Weak ↓ Weak Declining Year-over-year change in net income	-17.0% Weak ↓ Weak Declining Year-over-year change in net income	-16.7% Weak ↑ Weak Improving Year-over-year change in net income	11.5% Fair ↑ Fair Improving Year-over-year change in net income	-27.4% Weak ↑ Weak Improving Year-over-year change in net income	-51.1% Weak ↑ Weak Improving Year-over-year change in net income	-82.2% Weak ↑ Weak Improving Year-over-year change in net income	-152.0% Weak ↓ Weak Declining Year-over-year change in net income	-98.7% Weak → Weak Stable Year-over-year change in net income	-129.1% Weak Weak Year-over-year change in net income	-66.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	53.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	28.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-12.7% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	N/M	—	—	—	-154.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-11.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-18.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	37.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-26.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	35.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	40.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	21.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	117.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	78.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	75.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	59.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	117.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	289.8% Excellent Excellent Compound annual revenue growth over 3 years	487.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	24.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	20.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	67.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	38.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	152.8% Excellent Excellent Compound annual revenue growth over 5 years	200.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	-304.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2132%)	—	—	—	—	-377.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2614%)	—	—	—	—	—	—	-445.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3073%)	-475.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3270%)	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-304.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2635%)	—	—	—	—	-367.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3162%)	—	—	—	—	—	—	-420.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3603%)	-459.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3928%)	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-133.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	-385.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	181.6% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.19x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.20x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-1.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.63x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-14.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-19.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	9.0% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	10.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-11.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-15.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-10.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-7.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-11.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-9.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-15.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-18.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-21.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-17.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-18.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-222%)	-16.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-211%)	-22.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-20.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-21.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-16.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-15.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-11.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-15.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-15.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-11.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-12.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-7.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-6.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	13.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-12%)	12.5% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-17%)	13.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-13%)	11.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	13.0% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-13%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	-0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-109%)	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	-4817.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-3982.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3142.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3677.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-4813.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4727.93x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3998.64x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3418.95x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-210.92x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-122.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-110.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-56.04x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-42.76x Weak Weak Operating income divided by interest expense Optimal: > 5x	-60.94x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-545.68M	$-654.47M	$-743.29M	$-659.84M	$-525.11M	$-500.45M	$-594.35M	$-427.65M	$-474.34M	$-296.33M	—	$-387.32M	$-405.87M	$-473.14M	—	$-454.65M	$-453.88M	$-507.89M	—	$-393.98M	$-620.08M	$-201.41M	—	—	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.02x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.44x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.01	$0.01	—	$0.01	$0.05	$0.04	—	$0.09	$0.06	$0.06	—	$0.05	$0.05	$0.06	—	$0.08	$0.04	$0.03	—	$0.02	$0.02	$0.11	—	$0.05	$0.01	$0.00	—	—
Basic EPS, GAAP (USD)	$-0.25	$-0.22	$-0.17	$-0.36	$-0.41	$-0.50	$-0.57	$-0.34	$-0.40	$-0.39	$-0.42	$-0.43	$-0.38	$-0.34	$-0.30	$-0.35	$-0.38	$-0.33	$-0.39	$-0.28	$-0.31	$-1.33	$-1.17	$-1.09	$-0.88	$-0.85	—	—
Free Cash Flow per Share (USD)	$-0.20	$-0.15	—	$-0.26	—	$-0.33	—	—	—	$-0.46	—	—	—	$-0.41	—	—	—	$0.43	—	—	—	$-2.18	—	$-0.93	$-0.80	$-0.85	—	—
Book Value per Share (USD)	$1.71	$1.93	$2.14	$2.13	$2.12	$2.30	$2.61	$1.83	$2.08	$1.69	—	$2.02	$2.27	$2.24	—	$2.23	$2.53	$2.89	—	$3.55	$3.82	$-9.69	—	$-8.35	$-7.36	$-6.53	—	—
Tangible Book Value per Share (USD)	$0.88	$1.08	$1.25	$1.14	$0.96	$1.08	$1.39	$1.53	$1.76	$1.33	—	$1.60	$1.77	$2.23	—	$2.22	$2.52	$2.87	—	$3.54	$3.80	$-9.73	—	$-8.35	$-7.36	$-6.53	—	—
Basic Weighted Avg Shares (shares)	532.46M	529.30M	—	446.99M	417.36M	402.77M	—	282.58M	242.20M	236.02M	—	214.33M	201.42M	191.62M	—	173.44M	172.21M	170.69M	—	168.53M	138.36M	23.04M	—	21.82M	21.65M	21.64M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$483.58M	$579.86M	$665.14M	$559.00M	$423.13M	$442.16M	$526.80M	$365.28M	$436.29M	$269.69M	—	$316.40M	$317.06M	$399.98M	—	$398.58M	$449.34M	$533.75M	—	$557.93M	$618.10M	$194.97M	—	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$744.00K	$12.66M	$12.68M	—	—	—	—	—	—
Total Equity (USD)	$915.00M	$1.02B	$1.13B	$1.05B	$919.15M	$933.95M	$1.03B	$524.56M	$584.45M	$401.15M	$463.44M	$437.97M	$468.96M	$430.18M	$485.81M	$388.03M	$437.58M	$493.57M	$542.94M	$599.03M	$642.71M	$-233.03M	$-206.29M	$-182.07M	$-159.44M	$-141.39M	$-124.27M	$-63.85M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$7.67M	$6.47M	$35.54M	$5.17M	$19.22M	$14.74M	$4.55M	$26.08M	$14.42M	$13.79M	$10.89M	$10.53M	$11.02M	$12.13M	$13.68M	$13.16M	$7.67M	$5.33M	$2.53M	$2.53M	$2.55M	$2.56M	$2.69M	$1.02M	$186.00K	$60.00K	—	—
Depreciation Expense (USD)	$18.17M	$19.67M	$19.48M	$21.04M	—	$19.33M	$12.95M	$4.00M	$4.10M	$7.38M	$7.55M	$4.20M	$4.00M	$3.73M	$3.21M	$2.90M	$2.70M	$2.77M	$2.24M	$2.50M	$2.40M	$1.40M	$1.12M	$857.00K	$1.02M	$937.00K	—	—
Net Income, GAAP (USD)	$-131.00M	$-117.50M	$-108.12M	$-162.25M	$-171.90M	$-202.49M	$-178.91M	$-95.84M	$-97.54M	$-91.37M	$-93.00M	$-93.02M	$-76.73M	$-65.33M	$-57.49M	$-60.45M	$-65.56M	$-55.98M	$-64.93M	$-47.43M	$-43.40M	$-30.72M	$-25.77M	$-23.87M	$-18.94M	$-18.42M	—	—
Operating Cash Flow (USD)	$-105.95M	$-81.10M	$-46.07M	$-117.36M	—	$-131.96M	$-115.43M	—	—	$-102.30M	$-74.08M	—	—	$-73.32M	$-44.75M	—	—	$77.39M	$-61.16M	—	—	$-30.75M	$8.57M	$-19.46M	$-16.70M	$-17.82M	—	—

RECURSION PHARMACEUTICALS, INC.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RXRX with peers